Cellarity

Private

Somerville, MassachusettsHealthcare & Life Scienceshttps://www.cellarity.com

Last Round

Series C

Oct 4, 2022

Est. Valuation

$621M

Total Funding Raised

$294M

Company Overview

Cellarity is a biotechnology company that offers a biomedical platform designed to digitize and analyze molecular information in cells, enhancing the understanding of their behavior in health and disease to accelerate drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI drug discoverycellular behaviorAI biotechdrug discovery platformsingle-cell analysiscomputational biologyin silico drug discoverycell state correctiondigital twinsmall molecule therapeuticdrug safety predictiontherapeutic pipelinehematologyimmunologymetabolic diseaseMASH treatmentsickle cell disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellarity Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellarity Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Oct 4, 2022
Series B	Feb 25, 2021
Series A	Dec 10, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Ted Myles

Chief Executive Officer

Executive Team

Cellarity Investors

Notable investors and investment history

Investor	Rounds
Pictet Group	Series B
JIMCO	Series B
Flagship Pioneering	Series C, Series B, Series A
BlackRock	Series B
Hanwha Impact	Series C
The Baupost Group	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 4, 2025
Two oral presentations at the 67th ASH Annual Meeting.
May 12, 2025
Ted Myles appointed as the new Chief Executive Officer.

View all signals

Cellarity Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cellarity Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellarity's valuation, stock price, and market status.

Firmographic Details

HeadquartersSomerville, Massachusetts

Employee Range84

Year Founded2015

Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.